Hypertension and cardiovascular remodelling in rats exposed to continuous light: Protection by ACE-inhibition and melatonin

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Simko, Fedor ^a,b,c   Pechanova, Olga ^c,d   Repova Bednarova, Kristina ^a   Krajcirovicova, Kristina ^a   Celec, Peter ^a   Kamodyova, Natalia ^a   Zorad, Stefan ^b,c   Kucharska, Jarmila ^a   Gvozdjakova, Anna ^a   Adamcova, Michaela ^e   Paulis, Ludovit ^a,c  

^a Bratislava   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^c Center of Excellence NOREG   (Slovakia)

^d INSTITUTE OF CHEMISTRY   (Slovakia)

^e CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN II; CAPTOPRIL; COLLAGEN; HYDROXYPROLINE; MELATONIN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHROPOMETRIC PARAMETERS; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CONCENTRATION RESPONSE; CONTINUOUS LIGHT EXPOSURE; CONTROLLED STUDY; FIBRINOLYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART PROTECTION; HYPERTENSION; LIGHT EXPOSURE; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RAT; SYSTOLIC BLOOD PRESSURE; WISTAR RAT; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; LIGHT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; HYPERTENSION; LIGHT; MALE; MELATONIN; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84904633751     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/703175     Document Type: Article

References (62)

1. Reiter R. J., Manchester L. C., Fuentes-Broto L., Tan D., Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin. Journal of Hypertension 2010 28 1 S7 S12 10.1097/01.hjh.0000388488.51083.2b 2-s2.0-77957254402
2. Simko F., Pechanova O., Remodelling of the heart and vessels in experimental hypertension: advances in protection. Journal of Hypertension 2010 28 supplement 1 S1 S6 10.1097/01.hjh.0000388487.43460.db 2-s2.0-77957286607
3. Simko F., Matuskova J., Luptak I., Krajcirovicova K., Kucharska J., Gvozdjakova A., Babal P., Pechanova O., Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Life Sciences 2004 74 10 1211 1224 10.1016/j.lfs.2003.07.032 2-s2.0-0346880050 (Pubitemid 38022060)
4. Simko F., Pelouch V., Torok J., Luptak I., Matuskova J., Pechanova O., Babal P., Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ace-inhibition. Journal of Biomedical Science 2005 12 1 103 111 10.1007/s11373-004-8173-9 2-s2.0-17744398205 (Pubitemid 40576768)
5. Mandarim-de-Lacerda C. A., Pereira L. M. M., Effect of telmisartan on preexistent cardiac and renal lesions in spontaneously hypertensive mature rats. Histology and Histopathology 2004 19 3 727 733 2-s2.0-3042701246 (Pubitemid 38855054)
6. Simko F., Statins: a perspective for left ventricular hypertrophy treatment. European Journal of Clinical Investigation 2007 37 9 681 691 10.1111/j.1365-2362.2007.01837.x 2-s2.0-34547887250 (Pubitemid 47256168)
7. Kyselovic J., Krenek P., Wibo M., Godfraind T., Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats. The British Journal of Pharmacology 2001 134 7 1516 1522 10.1038/sj.bjp.0704398 2-s2.0-0035214284 (Pubitemid 33131902)
8. Simko F., Reiter R. J., Pechanova O., Paulis L., Experimental models of melatonin-deficient hypertension. Frontiers in Bioscience 2013 18 2 616 625 10.2741/4125 2-s2.0-84878775897
9. Ozturk M., Ozler M., Kurt Y. G., Ozturk B., Uysal B., Ersoz N., Yasar M., Demirbas S., Kurt B., Acikel C., Oztas Y., Arpaci F., Topal T., Ozet A., Ataergin S., Kuzhan O., Oter S., Korkmaz A., Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicin- and trastuzumab-induced cardiotoxicity. Journal of Pineal Research 2011 50 1 89 96 10.1111/j.1600-079X. 2010.00818.x 2-s2.0-78650154210
10. Grossini E., Molinari C., Uberti F., Mary D. A. S. G., Vacca G., Caimmi P. P., Intracoronary melatonin increases coronary blood flow and cardiac function through β -adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs. Journal of Pineal Research 2011 51 2 246 257 10.1111/j.1600-079X.2011.00886.x 2-s2.0-80051665469
11. Samimi-Fard S., Abreu-Gonzalez P., Dominguez-Rodriguez A., Jimenez-Sosa A., A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population. Journal of Pineal Research 2011 51 4 400 404 10.1111/j.1600-079X.2011.00903.x 2-s2.0-80054817942
12. Zeman M., Herichova I., Melatonin and clock genes expression in the cardiovascular system. Frontiers in Bioscience 2013 1 5 743 753
13. Simko F., Paulis L., Melatonin as a potential antihypertensive treatment. Journal of Pineal Research 2007 42 4 319 322 10.1111/j.1600-079X.2007.00436.x 2-s2.0-34147213902 (Pubitemid 46581667)
14. Tengattini S., Reiter R. J., Tan D., Terron M. P., Rodella L. F., Rezzani R., Cardiovascular diseases: protective effects of melatonin. Journal of Pineal Research 2008 44 1 16 25 10.1111/j.1600-079X.2007.00518.x 2-s2.0-36849008650 (Pubitemid 350231106)
15. Dominguez-Rodriguez A., Abreu-Gonzalez P., Sanchez-Sanchez J. J., Kaski J. C., Reiter R. J., Melatonin and circadian biology in human cardiovascular disease. Journal of Pineal Research 2010 49 1 14 22 10.1111/j.1600-079X.2010. 00773.x 2-s2.0-77954336406
16. Paulis L., Šimko F., Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. Physiological Research 2007 56 6 671 684 2-s2.0-41749116214
17. Hoffman R. A., Reiter R. J., Rapid pinealectomy in hamsters and other small rodents. The Anatomical Record 1965 153 1 19 21
18. Cunnane S. C., Manku M. S., Oka M., Horrobin D. F., Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin. Canadian Journal of Physiology and Pharmacology 1980 58 3 287 293 10.1139/y80-049 2-s2.0-0018891323 (Pubitemid 10135051)
19. Zanoboni A., Zanoboni-Muciaccia W., Experimental hypertension in pinealectomized rats. Life Sciences 1967 6 21 2327 2331 10.1016/0024-3205(67) 90043-4 2-s2.0-0014145872
20. Brown G. M., Bar-Or A., Grossi D., Kashur S., Johannson E., Urinary 6-sulphatoxymelatonin, an index of pineal function in the rat. Journal of Pineal Research 1991 10 3 141 147 10.1111/j.1600-079X.1991.tb00831.x 2-s2.0-0025837149
21. Tan D. X., Chen L. D., Poeggeler B., Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine Journal 1993 1 157 160
22. Reiter R. J., Tan D. X., Terron M. P., Flores L. J., Czarnocki Z., Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochimica Polonica 2007 54 1 1 9 2-s2.0-33947592217 (Pubitemid 46481811)
23. Galano A., Tan D. X., Reiter R. J., Melatonin as a natural ally against oxidative stress: a physicochemical examination. Journal of Pineal Research 2011 51 1 1 16 10.1111/j.1600-079X.2011.00916.x 2-s2.0-79960380554
24. Reiter R. J., Tan D. X., Melatonin: a multitasking molecule. Progress in Brain Research 2010 181 127 151 10.1016/S0079-6123(08)81008-4 2-s2.0-77955506965
25. Rezzani R., Porteri E., de Ciuceis C., Bonomini F., Rodella L. F., Paiardi S., Boari G. E. M., Platto C., Pilu A., Avanzi D., Rizzoni D., Agabiti Rosei E., Effects of melatonin and pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension 2010 55 6 1373 1380 10.1161/HYPERTENSIONAHA.109.148254 2-s2.0-77952950561
26. Reiter R. J., Tan D., Korkmaz A., The circadian melatonin rhythm and its modulation: possible impact on hypertension. Journal of Hypertension 2009 27 supplement 6 S17 S20 10.1097/01.hjh.0000358832.41181.bf 2-s2.0-68249122123
27. Dominguez-Rodriguez A., Abreu-Gonzalez P., Reiter R. J., Melatonin and cardiovascular disease: myth or reality? Revista Espanola de Cardiologia 2012 65 3 215 218 10.1016/j.recesp.2011.10.009 2-s2.0-84857501720
28. Paulis L., Matuskova J., Adamcova M., Pelouch V., Simko J., Krajcirovicova K., Potacova A., Hulin I., Janega P., Pechanova O., Simko F., Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone. Acta Physiologica 2008 194 1 45 55 10.1111/j.1748-1716.2008.01862.x 2-s2.0-48749087838
29. Benova T., Viczenczova C., Radosinska J., Bacova B., Knezl V., Dosenko V., Weismann P., Zeman M., Navarova J., Tribulova N., Melatonin attenuates hypertension-related proarrhythmic myocardial maladaptation of connexin-43 and propensity of the heart to lethalarrhythmias. Canadian Journal of Physiology and Pharmacology 2013 91 8 633 639 10.1139/cjpp-2012-0393 2-s2.0-84880737975
30. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M., Reiter R. J., Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction. The American Journal of Cardiology 2006 97 8 1162 1164 10.1016/j.amjcard.2005.11.033 2-s2.0-33645750415
31. Dominguez-Rodriguez A., Abreu-Gonzalez P., Reiter R. J., Clinical aspects of melatonin in the acute coronary syndrome. Current Vascular Pharmacology 2009 7 3 367 373 10.2174/157016109788340749 2-s2.0-69149109844
32. Dominguez-Rodriguez A., Abreu-Gonzalez P., Arroyo-Ucar E., Reiter R. J., Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction. Journal of Pineal Research 2012 53 3 319 323 10.1111/j.1600-079X.2012.01001.x 2-s2.0-84866263440
33. Dominguez-Rodriguez A., Abreu-Gonzalez P., Arroyo-Ucar E., Avanzas P., Reiter R. J., Global left ventricular longitudinal strain is associated with decreased melatonin levels in patients with acute myocardial infarction: a two-dimensional speckle tracking study. Biomarkers 2013 18 4 310 313 10.3109/1354750X.2013.778330 2-s2.0-84878137254
34. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M. J., Kaski J. C., Reiter R. J., Jimenez-Sosa A., A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty. The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale. Contemporary Clinical Trials 2007 28 4 532 539 10.1016/j.cct.2006.10.007 2-s2.0-34248564577 (Pubitemid 46755019)
35. Dominguez-Rodriguez A., Abreu-Gonzalez P., Reiter R. J., Melatonin and cardioprotection in the acute myocardial infarction: a promising cardioprotective agent. International Journal of Cardiology 2012 158 2 309 310 10.1016/j.ijcard.2012.04.110 2-s2.0-84862204819
36. Repova-Bednarova K., Aziriova S., Hrenak J., Effect of captopril and melatonin on fibrotic rebuilding of the aorta in 24 hour light-induced hypertension. Physiological Research 2013 62 supplement 1 S135 S141
37. Bernátová I., Pecháňová O., Pelouch V., Šimko F., Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy: effect of captopril. Journal of Molecular and Cellular Cardiology 2000 32 2 177 185 10.1006/jmcc.1999.1071 2-s2.0-0033847778
38. Simko F., Pechanova O., Pelouch V., Krajcirovicova K., Mullerova M., Bednarova K., Adamcova M., Paulis L., Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. Journal of Hypertension 2009 27 supplement 6 S5 S10 10.1097/01.hjh.0000358830.95439.e8 2-s2.0-68249131003
39. Pelouch V., Milerova M., Ostadal B., Samánek M., Hucín B., Protein profiling of human atrial and ventricular musculature: the effect of normoxaemia and hypoxaemia in congenital heart diseases. Physiological Research 1993 42 4 235 242 2-s2.0-0027736336
40. Pelouch V., Milerova M., Ostadal B., Hucin B., Samanek M., Differences between atrial and ventricular protein profiling in children with congenital heart disease. Molecular and Cellular Biochemistry 1995 147 1-4 43 49 10.1007/BF00944782 2-s2.0-0029047847
41. Reddy G. K., Enwemeka C. S., A simplified method for the analysis of hydroxyproline in biological tissues. Clinical Biochemistry 1996 29 3 225 229 10.1016/0009-9120(96)00003-6 2-s2.0-0029881336 (Pubitemid 26142071)
42. Munch G., Keis R., Wessels A., Riederer P., Bahner U., Heidland A., Niwa T., Lemke H.-., Schinzel R., Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA1. European Journal of Clinical Chemistry and Clinical Biochemistry 1997 35 9 669 677 2-s2.0-0030698699
43. Bhatwadekar A. D., Ghole V. S., Rapid method for the preparation of an AGE-BSA standard calibrator using thermal glycation. Journal of Clinical Laboratory Analysis 2005 19 1 11 15 (Pubitemid 40170595)
44. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C., Nguyen-Khoa T., Nguyen A. T., Zingraff J., Jungers P., Descamps-Latscha B., Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney International 1996 49 5 1304 1313 10.1038/ki.1996.186 2-s2.0-0029948839 (Pubitemid 26166404)
45. Lang J. K., Gohil K., Packer L., Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Analytical Biochemistry 1986 157 1 106 116 10.1016/0003-2697(86)90203-4 2-s2.0-0022552575 (Pubitemid 16028359)
46. Kucharská J., Gvozdjáková A., Šimko F., Simvastatin decreased coenzyme Q in the left ventricle and skeletal muscle but not in the brain and liver in L-NAME-induced hypertension. Physiological Research 2007 56 supplement 2 S49 S54 2-s2.0-38549093701
47. Zeman M., Dulková K., Bada V., Herichová I., Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sciences 2005 76 16 1795 1803 10.1016/j.lfs.2004.08.034 2-s2.0-13444278867 (Pubitemid 40215221)
48. Buijs R. M., Kalsbeek A., Hypothalamic integration of central and peripheral clocks. Nature Reviews Neuroscience 2001 2 7 521 526 10.1038/35081582 2-s2.0-0035407215 (Pubitemid 33676587)
49. Scheer F. A. J. L., van Montfrans G. A., van Someren E. J. W., Mairuhu G., Buijs R. M., Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004 43 2 192 197 10.1161/01.HYP.0000113293.15186.3b 2-s2.0-0842332600 (Pubitemid 38174173)
50. Jonas M., Garfinkel D., Zisapel N., Laudon M., Grossman E., Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Pressure 2003 12 1 19 24 2-s2.0-0037257378 (Pubitemid 36416949)
51. Simko F., Pechanova O., Pelouch V., Krajcirovicova K., Celec P., Palffy R., Bednarova K., Vrankova S., Adamcova M., Paulis L., Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril. Journal of Hypertension 2010 28 supplement 1 S13 S18 10.1097/01.hjh.0000388489.28213.08 2-s2.0-77957255604
52. Pechánová O., Zicha J., Paulis L., Zenebe W., Dobesová Z., Kojsová S., Jendeková L., Slá dková M., Dovinová I., Simko F., Kunes J., The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. European Journal of Pharmacology 2007 561 1-3 129 136 10.1016/j.ejphar.2007.01.035 2-s2.0-33947280466 (Pubitemid 46435853)
53. Paulis L., Pechanova O., Zicha J., Krajcirovicova K., Barta A., Pelouch V., Adamcova M., Simko F., Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats. Journal of Hypertension 2009 27 supplement 6 S11 S16 10.1097/01.hjh.0000358831.33558.97 2-s2.0-70349297077
54. Weber K. T., From inflammation to fibrosis: a stiff stretch of highway. Hypertension 2004 43 4 716 719 10.1161/01.HYP.0000118586.38323.5b 2-s2.0-1642542477 (Pubitemid 38405574)
55. Simko F., Simko J., The potential role of nitric oxide in the hypertrophic growth of the left ventricle. Physiological Research 2000 49 1 37 46 2-s2.0-0033956274 (Pubitemid 30111295)
56. Simko F., Is NO the king? Pathophysiological benefit with uncertain clinical impact [editorial]. Physiological Research 2007 56 supplement 2 S1 S6
57. Karppanen H., Lahovaara S., Männistö P., Vapaatalo H., Plasma renin activity and in vitro synthesis of aldosterone by the adrenal glands of rats with spontaneous, renal, or pinealectomy induced hypertension. Acta Physiologica Scandinavica 1975 94 2 184 188 10.1111/j.1748-1716.1975.tb05878.x 2-s2.0-0016684978
58. Milosievic V., Trifunovic S., Sekulic M., Chronic exposure to constant light affects morphology and secretion of adrenal zona fascikulata cells in female rats. General Physiology and Biophysics 2005 24 3 299 309 (Pubitemid 41723835)
59. Li H., Kang Y., Yu L., Xu H., Zhao H., Melatonin reduces blood pressure in rats with stress-induced hypertension viaGABAA receptors. Clinical and Experimental Pharmacology and Physiology 2009 36 4 436 440 10.1111/j.1440-1681. 2008.05080.x 2-s2.0-68849120599
60. Reiter R. J., Tan D. X., Manchester L. C., Pilar Terron M., Flores L. J., Koppisepi S., Medical implications of melatonin: receptor-mediated and receptor-independent actions. Advances in Medical Sciences 2007 52 11 28 2-s2.0-39749108884
61. Koziróg M., Poliwczak A. R., Duchnowicz P., Koter-Michalak M., Sikora J., Broncel M., Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. Journal of Pineal Research 2011 50 3 261 266 10.1111/j.1600-079X.2010.00835.x 2-s2.0-79952550270
62. Simko F., Simko J., Fabryova M., ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: pathophysiological consideration of the unresolved battle. Cardiovascular Drugs and Therapy 2003 17 3 287 290 10.1023/A:1026215712983 2-s2.0-0242721462 (Pubitemid 37421745)